Skip to content

Clinical Effect of "Qu-Zhuo-Tong-Bi" Recipe on Intercritical and Chronic Gout

Clinical Study on the Effect of "Qu-Zhuo-Tong-Bi" Recipe on Intercritical and Chronic Gout

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12001923
Enrollment
Unknown
Registered
2012-02-08
Start date
2008-10-15
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary gout

Interventions

Treatment Group:Basic recipe and Herbs of Symptomatic Therapy
control group:placebo

Sponsors

Zhejinag University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 68 Years

Inclusion criteria

Inclusion criteria: The patients enrolled in this study are males diagnosed with primary gout, chronic gout and the "syndrome of damp abundance due to splenic asthenia". Our diagnosis standards of primary gout and chronic gout were based on the criteria for the classification of primary gout revised by the American College of Rheumatology in 19778 and the guidelines for the diagnosis and treatment of primary gout revised by the Rheumatism Branch of Chinese Medical Association in 20039. The syndrome of damp abundance due to splenic asthenia was diagnosed according to the Curative Standard for TCM Diagnosis revised by the State Administration of TCM, which include the following symptoms: dull pain in joints, fatigue, abdominal distension, anorexia, loose stool, red tongue with white greasy fur or powder greasy fur, and slippery pulse combined with continuous hyperuricemia. In addition, patients included should have a serum UA level >=480umol/L, age 18 to 60 years old, voluntarily join the trial, and agree to sign an informed consent certificate.

Exclusion criteria

Exclusion criteria: Patients were excluded from the study if they were in any of the following situations: diagnosed as acute gouty arthritis, gouty stone or secondary gout, had taken medicines to reduce UA levels within 2 weeks before the study, had a serum creatinine level >=133umol/L, had urinary calculi, had a serious organ dysfunction, had mental illness or cancer, had a body mass index >=50kg/m2, and were alcoholic.

Design outcomes

Primary

MeasureTime frame
serum uric acide;

Secondary

MeasureTime frame
Recurrence of Joint Swelling and Pain;Blood routine;Urine routine;Blood biochemistry parameter;

Countries

China

Contacts

Public ContactWen Chengping
wengcp@163.com+86 0571 86613644

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026